[Carcinofetal alterations in isozymes, with special reference to glycogen phosphorylase (author's transl)].
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000032:analysis; D000818:Animals; D005260:Female; D005333:Fetus / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D006006:Glycogen Synthase / Q000032:analysis; D006593:Hexokinase / Q000032:analysis; D006801:Humans; D007527:Isoenzymes / Q000032:analysis*; D008099:Liver / Q000196:embryology / Q000201:enzymology; D008112:Liver Glycogen / Q000378:metabolism; D008113:Liver Neoplasms / Q000201:enzymology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000201:enzymology; D010732:Phosphofructokinase-1 / Q000032:analysis; D006005:Phosphorylases / Q000032:analysis*; D011247:Pregnancy; D011494:Protein Kinases / Q000032:analysis; D011817:Rabbits; D051381:Rats
D007527:Isoenzymes; D008112:Liver Glycogen; D006005:Phosphorylases; D006006:Glycogen Synthase; D011494:Protein Kinases; D006593:Hexokinase; D010732:Phosphofructokinase-1; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D005634:Fructose-Bisphosphate Aldolase